|
|
|
|
|
|
|
|
|
|
|
|
Bone marrow (100895)
Sponsor: COG (ANHL 0221)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Phase II Study of the Combination of Cyclophosphamide, Prednisone, and Rituximab (CPR) in Children, Adolescents and Young Adults with CD20 Positive Post-Transplant Lymphoproliferative Disease (PTLD) Following Solid Organ Transplant (SOT)
None Available
|
 |
|
|
More...
|
|
|
|
|
Brain (100901)
Sponsor: COG (ACNS0423)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Phase II Study of Concurrent Radiation and Temozolomide Followed by Temozolomide and CCNU in the Treatment of Children with High Grade Glioma
None Available
|
|
|
|
|
More...
|
|
|
|
|
|
Brain (100933)
Sponsor: COG (ANBL 00P3)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Phase III Randomized Trial of Intravenous Gammaglobulin Therapy for Patients with Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated With Chemotherapy and Prednisone
None Available
|
|
|
|
|
More...
|
|
|
|
|
Brain (101011)
Sponsor: COG (ACNS 0331)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma - Phase II Double Randomized
None Available
|
|
|
|
|
More...
|
|
|
|
|
Brain (101113)
Sponsor: COG (ACNS 0332)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients
None Available
|
|
|
|
|
More...
|
|
|
|
Brain (101146)
Sponsor: COG (ACNS0222)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Phase II Study Of Motexafin-Gadolinium (Nsc 695238, Ind #55583) And Involved Field Radiation Therapy For Intrinsic Pontine Glioma Of Childhood
None Available
|
|
|
|
|
More...
|
|
|
|
Brain (101157)
Sponsor: COG (ANBL0032)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
Phase III Randomized Study of Chimeric Antibody 14.18 (Ch 14.18) in High Risk Neuroblastome following Myeloablatice Therapy and Autogolous Stem Cell Rescue
None Available
|
|
|
|
|
More...
|
|
|
|
Brain (101159)
Sponsor: COG (ACNS0334)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 months Old With Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue vs the Same Therapy without Methotrexate
None Available
|
|
|
|
|
More...
|
|
|
|
|
|
Eye (100970)
Sponsor: COG (ARET0332)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy
None Available
|
|
|
|
|
More...
|
|
|
|
|
|
|
|
|
|
|
|
|
Leukemia (101068)
Sponsor: COG (AAML 0531)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Phase II Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg) Conbimed with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescent, and Young Adults.
None Available
|
|
|
|
|
More...
|
|
|
|
Leukemia (101088)
Sponsor: COG (0501)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
Multi-center, Open Label, Randomized Trial Comparing Single Versus Double Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients with High Risk Leukemia and Myelodysplasia.
None Available
|
|
|
|
|
More...
|
|
|
|
Leukemia (101093)
Sponsor: COG (AALL 0434)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia
None Available
|
|
|
|
|
More...
|
|
|
|
|
Leukemia (101111)
Sponsor: COG (AALL 0433)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
Intensive treatment for intermediate-risk relapse of childhood B-Precursor acute lymphoblastic leukemia (all): A randomized trial of vincristine strategies
None Available
|
|
|
|
|
More...
|
|
|
|
|
Leukemia (101120)
Sponsor: COG (ADVL04P2)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Feasibility Pilot and Phase 2 Study of Chemoimmunotherapy with Epratuzumab for Children with Relapsed CD22-Positive Acute Lymphoblastic Leukemia.
None Available
|
|
|
|
|
More...
|
|
|
|
Leukemia (101221)
Sponsor: COG (AALL0631)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLTS3 Inhibition (CEP-701, Lestaurtinib; IND#76431; NSC# 617807)
None Available
|
|
|
|
|
More...
|
|
|
|
Leukemia (101227)
Sponsor: COG (AAML05P1)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
Killer ImmunoglobuLin-like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Cell
Transplantation (HCT) for Refractory and Relapsed Acute Myelogenous Leukemia (AML) and newly diagnosed AML with monosomy 7 or -5/5q- in Children: A Children's Oncology Group
(COG) Study
None Available
|
|
|
|
|
More...
|
|
|
|
|
Lung-NSC (101162)
Sponsor: COG (ASCT0521)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation
None Available
|
|
|
|
|
More...
|
|
|
|
Lymphoma (100951)
Sponsor: COG (AHOD0031)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Phase III Group-Wide Study of Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly Diagnosed Intermediate Risk Hodgkin's Disease
None Available
|
|
|
|
|
More...
|
|
|
|
|
|
Lymphoma (101091)
Sponsor: COG (AHOD0521)
|
By Pediatric on
7/2/2009 4:00 AM
|
|
|
A Phase II Study of Bortezomib (Velcade, PS-341, IND #58443) in Combination with Ifosfamide/Vinorelbine in Pediatric Patients and Young Adults with Refractory/Recurrent Hodgkin Disease.
None Available
|
|
|
|
|
More...
|
|